XML 59 R48.htm IDEA: XBRL DOCUMENT v3.24.2
Fair Value of Financial Instruments - Narrative (Details)
$ in Millions
6 Months Ended
Jun. 30, 2024
USD ($)
Fair Value, Option, Quantitative Disclosures [Line Items]  
Change in fair value of the contingent financial asset and contingent financial liabilities $ 0.1
Fair Value, Net Derivative Asset (Liability), Recurring Basis, Still Held, Unrealized Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] General and administrative
2.625% Convertible Senior Notes due 2027 | Convertible Debt  
Fair Value, Option, Quantitative Disclosures [Line Items]  
Long-term debt $ 575.0
Debt instrument, fair value 715.1
Progenics  
Fair Value, Option, Quantitative Disclosures [Line Items]  
Potential payments, high 85.0
Progenics | Net Sales Targets for Azedra  
Fair Value, Option, Quantitative Disclosures [Line Items]  
Potential payments, high 70.0
Progenics | 1095 commercialization milestone  
Fair Value, Option, Quantitative Disclosures [Line Items]  
Potential payments, high 5.0
Progenics | 1404 Commercialization Milestone  
Fair Value, Option, Quantitative Disclosures [Line Items]  
Potential payments, high $ 10.0